Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre; Arduino Aleksander Mangoni

doi:10.7573/DIC.2020-12-1

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre
, Arduino Aleksander Mangoni

College of Medicine and Public Health

Research output: Contribution to journal › Editorial

34 Downloads (Pure)

Abstract

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Original language	English
Article number	10
Number of pages	3
Journal	Drugs in Context
Volume	10
DOIs	https://doi.org/10.7573/DIC.2020-12-1
Publication status	Published - Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Connective tissue diseases
Cyclophosphamide
Interstitial lung diseases
Mycophenolate
Nintedanib
Pierfenidone
Rituximab

Access to Document

10.7573/DIC.2020-12-1Licence: CC BY-NC-ND

Published versionFinal published version, 202 KBLicence: CC BY-NC-ND

Cite this

@article{4c64e2dcb579477a989886394b333f9e,

title = "Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue ",

abstract = "This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.",

keywords = "Connective tissue diseases, Cyclophosphamide, Interstitial lung diseases, Mycophenolate, Nintedanib, Pierfenidone, Rituximab",

author = "Erre, \{Gian Luca\} and Mangoni, \{Arduino Aleksander\}",

year = "2021",

month = jan,

doi = "10.7573/DIC.2020-12-1",

language = "English",

volume = "10",

journal = "Drugs in Context",

issn = "1745-1981",

publisher = "Bioexcel Publishing LTD",

}

TY - JOUR

T1 - Current therapeutic strategies in connective tissue disease-related interstitial lung disease

T2 - introduction to the special issue

AU - Erre, Gian Luca

AU - Mangoni, Arduino Aleksander

PY - 2021/1

Y1 - 2021/1

N2 - This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

AB - This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

KW - Connective tissue diseases

KW - Cyclophosphamide

KW - Interstitial lung diseases

KW - Mycophenolate

KW - Nintedanib

KW - Pierfenidone

KW - Rituximab

UR - https://www.scopus.com/pages/publications/85100655732

U2 - 10.7573/DIC.2020-12-1

DO - 10.7573/DIC.2020-12-1

M3 - Editorial

AN - SCOPUS:85100655732

SN - 1745-1981

VL - 10

JO - Drugs in Context

JF - Drugs in Context

M1 - 10

ER -

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this